Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Latest action: Referred to the House Committee on Energy and Commerce. · Oct 10, 2025

View full text on Congress.gov ↗ Policy area: Health